<SEC-DOCUMENT>0001658247-25-000008.txt : 20250926
<SEC-HEADER>0001658247-25-000008.hdr.sgml : 20250926
<ACCEPTANCE-DATETIME>20250925173634
ACCESSION NUMBER:		0001658247-25-000008
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250925
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250926
DATE AS OF CHANGE:		20250925

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Crinetics Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001658247
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				263744114
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38583
		FILM NUMBER:		251344905

	BUSINESS ADDRESS:	
		STREET 1:		6055 LUSK BLVD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-450-6464

	MAIL ADDRESS:	
		STREET 1:		6055 LUSK BLVD.
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>crnx-20250925.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:318da7fd-a5a8-4cea-9de6-b1786bd0a538,g:f7c2374b-5a51-4ff0-845f-44fdc0a6f28a,d:49945206630e4c8a8de114a79ab11986-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>crnx-20250925</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0001658247</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="crnx-20250925.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001658247</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-25</xbrli:startDate><xbrli:endDate>2025-09-25</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i49945206630e4c8a8de114a79ab11986_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:9.35pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-bottom:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">September&#160;25, 2025</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-bottom:14pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Crinetics Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of Registrant as Specified in Its Charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38583</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">26-3744114</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:120%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:120%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:120%">(IRS Employer<br/>Identification No.)</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">6055 Lusk Boulevard</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">92121</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of Principal Executive Offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:120%">(Zip Code)</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">858</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">450-6464</ix:nonNumeric></span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">_________________________________________________________</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.051%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.356%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-top:0.25pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">CRNX</ix:nonNumeric></span></td><td colspan="3" style="border-top:0.25pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#8239;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#8239;240.12b-2 of this chapter).</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">o</ix:nonNumeric></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div></div><div id="i49945206630e4c8a8de114a79ab11986_4"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01 Regulation FD Disclosure.</span></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 25, 2025, Crinetics Pharmaceuticals, Inc. (the &#8220;Company,&#8221; &#8220;Crinetics,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) issued a press release announcing that the U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved PALSONIFY</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%"> (paltusotine) for the first-line treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option. PALSONIFY, a selectively-targeted somatostatin receptor type 2 nonpeptide (&#8220;SST2&#8221;) agonist, is now the first once-daily, oral treatment approved for adults with acromegaly. </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company intends to hold an investor conference call on September 25, 2025 at 6:00 pm Eastern Time to discuss the FDA approval of PALSONIFY.  The press release, as well as a replay of the investor conference call, will also be available under the &#8220;Investors&#8221; section of the Company&#8217;s website.  </span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in this Item 7.01 of this Current Report on Form 8-K, including in Exhibit 99.1 hereto, is being &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), is not subject to the liabilities of that section and is not deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.</span></div><div id="i49945206630e4c8a8de114a79ab11986_549755813982"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01 Other Events.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">On September 25, 2025, the FDA approved PALSONIFY for the first-line treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option. PALSONIFY, a selectively-targeted somatostatin receptor type 2 nonpeptide (&#8220;SST2&#8221;) agonist, is now the first once-daily, oral treatment approved for adults with acromegaly.</span></div><div style="margin-bottom:18pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Exchange Act. All statements other than statements of historical facts contained in this Current Report on Form 8-K are forward-looking statements. These forward-looking statements speak only as of the date of this Current Report on Form 8-K and are subject to a number of known and unknown risks, uncertainties and assumptions, including, without limitation, the risks and uncertainties described in the Company&#8217;s periodic filings with the Securities and Exchange Commission (&#8220;SEC&#8221;). The events and circumstances reflected in the Company&#8217;s forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Additional information on risks facing Crinetics can be found under the heading &#8220;Risk Factors&#8221; in Crinetics&#8217; periodic filings with the SEC, including its annual report on Form 10-K for the year ended December 31, 2024. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by applicable law, Crinetics does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</span></div><div id="i49945206630e4c8a8de114a79ab11986_7"></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-bottom:10pt;padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.84pt">Exhibits</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.030%"><tr><td style="width:1.0%"/><td style="width:9.255%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.927%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:9pt;font-weight:700;line-height:120%">Description</span></td></tr><tr style="height:11pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #ffffff;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="crnx-2025925ex991.htm">Press Release dated September 25, 2025.</a></span></div></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div></div><div id="i49945206630e4c8a8de114a79ab11986_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9.35pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.354%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Crinetics Pharmaceuticals, Inc.</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">September&#160;25, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">/s/ R. Scott Struthers, Ph.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',serif;font-size:10pt;font-weight:400;line-height:120%">R. Scott Struthers, Ph.D.<br/>President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>crnx-2025925ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ifce518df56ee47babe96e222effdaabe_1"></div><div style="min-height:79.2pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><img alt="img113038668_0.jpg" src="img113038668_0.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:168px"></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%">Crinetics Announces FDA Approval of PALSONIFY</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:12pt;font-weight:700;line-height:120%"> (paltusotine) for the Treatment of Adults with Acromegaly</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:112%">Novel nonpeptide SST2 agonist PALSONIFY advances the treatment paradigm as the first once-daily, oral therapy approved by the FDA to treat acromegaly</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:112%">Approval based on data from two pivotal Phase 3 trials where PALSONIFY was well tolerated and resulted in rapid, durable, and consistent biochemical control and reduced symptom burden</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:112%">Launch of lead product PALSONIFY marks a pivotal milestone for Crinetics as the premier endocrine-focused global pharmaceutical company</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:112%">Investor call to be held today at 6&#58;00 pm ET</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:115%">SAN DIEGO &#8211; Sept. 25, 2025</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:115%"> &#8211; Crinetics Pharmaceuticals, Inc. (Nasdaq&#58; CRNX) today announced that the U.S. Food and Drug Administration (FDA) approved PALSONIFY</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.82pt;font-weight:400;line-height:115%;position:relative;top:-3.67pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:115%"> (paltusotine) for the first-line treatment of adults with acromegaly who had an inadequate response to surgery and&#47;or for whom surgery is not an option.  PALSONIFY, a selectively-targeted somatostatin receptor type 2 nonpeptide (SST2) agonist, is now the first once-daily, oral treatment approved for adults with acromegaly.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8220;With the FDA approval of our lead therapy Palsonify, today marks a new era for those living with acromegaly and also for Crinetics as a company,&#8221; said Scott Struthers, Ph.D., Founder and Chief Executive Officer of Crinetics. &#8220;We are very pleased to be fulfilling our commitment to transforming patient lives. This approval is the first to come from our deep pipeline of first-in-class, small molecule drugs. This would not be possible without the help and partnership of people living with acromegaly, their caretakers, our employees, and the clinical researchers and health care professionals who contributed to Palsonify&#8217;s successful development program. Thank you to all involved.&#8221;  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">The approval is based on data from the PATHFNDR-1 and PATHFNDR-2 Phase 3 pivotal trials, which evaluated PALSONIFY&#8217;s safety and efficacy in previously treated and medically untreated adults with acromegaly.  Across both trials, PALSONIFY consistently demonstrated rapid onset, reliable biochemical control, and sustained efficacy. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Participants also reported significant reductions in signs and symptoms associated with acromegaly as measured by the Acromegaly Symptom Diary (ASD) &#8212; an FDA-aligned patient-reported outcome tool developed to capture the symptoms that matter to people living with acromegaly. Symptoms include headaches, joint pain, sweating, fatigue, weakness, swelling, and&#47;or numbness&#47;tingling. PALSONIFY was generally well-tolerated, with no serious adverse events reported in the randomized controlled portion of the trial. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Long-term results from the open-label extension (OLE) phases of both trials were presented at this year&#8217;s Endocrine Society&#8217;s annual meeting, ENDO 2025, providing further evidence of PALSONIFY&#8217;s ability to deliver durable IGF-1 control, sustained improvements in patient symptom burden, and a consistent safety profile. Ninety-one percent of patients from PATHFNDR-1 and 97 percent of completers from PATHFNDR-2 enrolled in the OLE.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8220;The PATHFNDR clinical development program set a new standard for acromegaly treatment by demonstrating the ability of Palsonify to drive both biochemical and symptom control, regardless of the degree of underlying disease severity,&#8221; said Dr. Shlomo Melmed, Executive Vice President of Medicine and Health Sciences and Dean of the Medical Faculty at Cedars-Sinai. &#8220;The approval of Palsonify is a significant advancement for our patients, as there is an unmet need for an easy-to-administer and safe therapeutic option with a rapid action and durable response that can consistently manage acromegaly.&#8221;  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8220;For people living with acromegaly, treatment once meant burdensome injections, breakthrough symptoms, and lifestyle sacrifices just to stay on track,&#8221; said Jill Sisco, President of Acromegaly Community. &#8220;What matters most to our community &#8211; maintaining consistent control so the disease doesn&#8217;t control us &#8211; led us to partner with the FDA on Externally Led Patient-Focused Drug Development meetings. This new treatment reflects that our voices have been heard in shaping the next generation of acromegaly care.&#8221;</font></div><div><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-bottom:12pt"><img alt="img113038668_0.jpg" src="img113038668_0.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:168px"></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">PALSONIFY is expected to be available in the U.S. in early October. Crinetics is ensuring broad access to PALSONIFY by working closely with payers, healthcare providers, and patient advocacy organizations to support those who may benefit from this treatment.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">As part of this commitment, Crinetics has launched CrinetiCARE&#174;, a comprehensive support program designed to assist people living with acromegaly throughout their treatment journey. CrinetiCARE provides disease and product education, benefit verification, financial assistance resources, and access to dedicated nurse educators who can offer support with treatment onboarding and ongoing adherence. For more information, visit www.CrinetiCARE.com or the PALSONIFY product website Palsonify.com.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">A Marketing Authorization Application (MAA) for paltusotine in acromegaly is currently under review for use in the European Union, and the current timeline for the Committee for Medicinal Products and Human Use (CHMP) opinion is the first half of 2026. Crinetics is in partnership with Sanwa Kagaku Kenkyuso (SKK) to develop and commercialize paltusotine for acromegaly in Japan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Paltusotine is also being evaluated for the treatment of carcinoid syndrome in the pivotal Phase 3 CAREFNDR trial. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">Conference Call and Webcast</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">Crinetics will host an investor conference call today at 6&#58;00 pm Eastern Time to discuss the FDA approval of PALSONIFY. Following the live event, a replay will be available on the Investors section of the Company&#8217;s website.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">Dial-in Details&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">Domestic&#58; 1-833-470-1428</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">International&#58; 1-646-844-6383</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">Conference ID&#58; 120796</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Webcast&#58; https&#58;&#47;&#47;events.q4inc.com&#47;attendee&#47;443074040</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">PALSONIFY</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.82pt;font-weight:700;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%"> (paltusotine) INDICATION&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">PALSONIFY is a somatostatin receptor agonist indicated for the treatment of adults with acromegaly who had an inadequate response to surgery and&#47;or for whom surgery is not an option.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">IMPORTANT SAFETY INFORMATION</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">WARNINGS AND PRECAUTIONS&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%;padding-left:14.33pt">Cholelithiasis and</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%">Its Complications&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Cholelithiasis, including related complications such as acute cholecystitis and pancreatitis, have been reported. Monitor patients periodically. Discontinue PALSONIFY if complications of cholelithiasis occur and treat appropriately. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%;padding-left:14.33pt">Hyperglycemia and Hypoglycemia&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Hyperglycemia, diabetes mellitus, or hypoglycemia, may occur. Monitor blood glucose levels when PALSONIFY treatment is initiated or when dosage is altered. Adjust antidiabetic treatment accordingly. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%;padding-left:14.33pt">Cardiovascular Abnormalities&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%"> Cardiac conduction abnormalities and other ECG changes such as PR interval prolongation, bradycardia, sinus arrest, and atrioventricular block may occur in patients with acromegaly and were reported in PALSONIFY clinical trials. Dosage adjustments of concomitant drugs that have bradycardic effects may be necessary. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%;padding-left:14.33pt">Thyroid Function Abnormalities&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%"> Somatostatin analogs may suppress the secretion of thyroid-stimulating hormone, which may result in hypothyroidism. Periodic assessment of thyroid function is recommended. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%;padding-left:14.33pt">Steatorrhea and Malabsorption of Dietary Fats&#58; </font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Somatostatin analog treatment may result in malabsorption of dietary fats and subsequent symptoms of steatorrhea, loose stools, abdominal bloating, and weight loss. If new or worsening symptoms are reported with PALSONIFY, evaluate patients for potential pancreatic exocrine insufficiency and manage accordingly. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%;padding-left:14.33pt">Vitamin B</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.82pt;font-weight:700;line-height:112%;position:relative;top:1.48pt;vertical-align:baseline">12</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%"> Deficiency&#58;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%"> Vitamin B</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.82pt;font-weight:400;line-height:112%;position:relative;top:1.48pt;vertical-align:baseline">12</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%"> deficiency may occur. Monitor vitamin B</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.82pt;font-weight:400;line-height:112%;position:relative;top:1.48pt;vertical-align:baseline">12</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%"> levels, if clinically indicated. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%">ADVERSE REACTIONS&#58; </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-bottom:12pt"><img alt="img113038668_0.jpg" src="img113038668_0.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:168px"></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Most common adverse reactions (&#62;5%) are diarrhea, abdominal pain, nausea, decreased appetite, sinus bradycardia, hyperglycemia, palpitations, and gastroenteritis.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%">DRUG INTERACTIONS&#58; </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%;padding-left:14.33pt">Strong or Moderate CYP3A4 Inducers&#58; may decrease PALSONIFY exposure. May require an increased dosage of PALSONIFY. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%;padding-left:14.33pt">Proton Pump Inhibitors&#58; may decrease PALSONIFY exposure. May require an increased dosage of PALSONIFY. Avoid concomitant use of proton pump inhibitors in patients who are already on PALSONIFY 60 mg. </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%;padding-left:14.33pt">Cyclosporine&#58; may decrease cyclosporine exposure. May require cyclosporine dosage adjustment when used with PALSONIFY&#59; follow therapeutic monitoring recommendations.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:112%">Please report adverse events to Crinetics Pharmaceuticals at 1-833-CRN-INFO (1-833-276-4636) or FDA at 1-800-FDA-1088 or www.fda.gov&#47;medwatch. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Please see Full Prescribing Information including Patient Information.</font></div><div style="text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">About PALSONIFY&#8482; (Paltusotine)</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:115%">PALSONIFY, a selectively-targeted somatostatin receptor type 2 (SST2) nonpeptide agonist is the first and only once-daily, oral therapy approved for the treatment of adults with acromegaly who had an inadequate response to surgery and&#47;or for whom surgery is not an option. In Phase 3 studies, once-daily, oral PALSONIFY maintained IGF-1 levels and symptom control in patients with acromegaly who were switched from monthly injectable medications (PATHFNDR-1) and rapidly decreased IGF-1 levels and symptom burden in medically untreated acromegaly patients (PATHFNDR-2). IGF-1 is the primary biomarker endocrinologists use to manage acromegaly patients. Paltusotine is also in Phase 3 clinical development for carcinoid syndrome associated with neuroendocrine tumors (CAREFNDR). Results from a Phase 2 study in carcinoid syndrome demonstrated rapid and sustained reductions in flushing episodes and bowel movement frequency, which are the most common symptoms of carcinoid syndrome. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">About Crinetics Pharmaceuticals </font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Crinetics Pharmaceuticals is a global pharmaceutical company committed to transforming the treatment of endocrine diseases and endocrine-related tumors through science rooted in patient needs. Crinetics is focused on discovering, developing, and commercializing novel therapies, with a core expertise in targeting G-protein coupled receptors (GPCRs) with small molecules that have specifically tailored pharmacology and properties.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%">Crinetics&#8217; lead product, PALSONIFY</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:6.82pt;font-weight:400;line-height:112%;position:relative;top:-3.67pt;vertical-align:baseline">TM</font><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:112%"> (paltusotine), is the first once-daily, oral treatment approved by the U.S. FDA for the treatment of adults with acromegaly who had an inadequate response to surgery and&#47;or for whom surgery is not an option. Paltusotine is also in clinical development for carcinoid syndrome associated with neuroendocrine tumors. Crinetics&#8217; deep pipeline of 10+ disclosed programs includes late-stage investigational candidate atumelnant, which is currently in late-stage development for congenital adrenal hyperplasia and ACTH-dependent Cushing&#8217;s syndrome.  Additional discovery programs address a variety of endocrine conditions such as neuroendocrine tumors, Graves&#8217; disease (including Graves&#8217; hyperthyroidism and Graves&#8217; orbitopathy, or thyroid eye disease), polycystic kidney disease, hyperparathyroidism, diabetes, obesity, and GPCR-targeted oncology indications.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:112%">This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements regarding the approval of additional product candidates in our pipeline&#59; the timeline of availability of PALSONIFY in the U.S.&#59; the timeline of the Committee for Medicinal Products and Human Use (CHMP)&#8217;s opinion regarding PALSONIFY&#59; the plan to develop and commercialize paltusotine for acromegaly in Japan&#59; the plans and timelines for the clinical development of atumelnant and paltusotine for the treatment of carcinoid syndrome, including the therapeutic potential and clinical benefits or safety profiles thereof and the timeline for global enrollment for CAREFNDR&#59; or the therapeutic potential for our development candidates to transition to clinical development&#59; . In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;could,&#8221; &#8220;intend,&#8221; &#8220;target,&#8221; &#8220;project,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; </font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:79.2pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="margin-bottom:12pt"><img alt="img113038668_0.jpg" src="img113038668_0.jpg" style="height:57px;margin-bottom:5pt;vertical-align:text-bottom;width:168px"></div></div><div><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-style:italic;font-weight:400;line-height:112%">&#8220;potential,&#8221; &#8220;upcoming&#8221; or &#8220;continue&#8221; or the negative of these terms or other similar expressions. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, including, without limitation, data that we report may change following completion or a more comprehensive review of the data related to the clinical studies, and the FDA and other regulatory authorities may not agree with our interpretation of such results&#59; we may not be able to obtain, maintain and enforce our patents and other intellectual property rights, and it may be prohibitively difficult or costly to protect such rights&#59; geopolitical events may disrupt Crinetics&#8217; business and that of the third parties on which it depends, including delaying or otherwise disrupting its clinical studies and preclinical studies, manufacturing and supply chain, or impairing employee productivity&#59; unexpected adverse side effects, complications and&#47;or drug interactions or inadequate efficacy of the Company&#8217;s product candidates that may limit their development, regulatory approval and&#47;or commercialization&#59; the Company&#8217;s dependence on third parties in connection with product manufacturing, research and preclinical and clinical testing&#59; the success of Crinetics&#8217; clinical studies and nonclinical studies&#59; regulatory developments or political changes, including policies related to pricing and pharmaceutical drug reimbursement, in the United States and foreign countries&#59; clinical studies and preclinical studies may not proceed at the time or in the manner expected, or at all&#59; the timing and outcome of research, development and regulatory review is uncertain, and Crinetics&#8217; drug candidates may not advance in development or be approved for marketing&#59; Crinetics may use its capital resources sooner than expected or our cash burn rate may accelerate&#59; any future impacts to our business resulting from geopolitical developments outside our control&#59; and the other risks and uncertainties described in the Company&#8217;s periodic filings with the Securities and Exchange Commission (SEC). The events and circumstances reflected in the company&#8217;s forward-looking statements may not be achieved or occur and actual results could differ materially from those projected in the forward-looking statements. Additional information on risks facing Crinetics can be found under the heading &#8220;Risk Factors&#8221; in Crinetics&#8217; periodic filings with the SEC, including its annual report on Form 10-K for the year ended December 31, 2024. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Except as required by applicable law, Crinetics does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">Media&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">Natalie Badillo</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">Head of Corporate Communications</font></div><div style="text-align:justify"><font style="color:#0070c0;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">nbadillo&#64;crinetics.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">(858) 345-6075</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:700;line-height:120%">Investors&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">Gayathri Diwakar</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">Head of Investor Relations</font></div><div style="text-align:justify"><font style="color:#0070c0;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">gdiwakar&#64;crinetics.com</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',serif;font-size:10.5pt;font-weight:400;line-height:120%">(858) 345-6340</font></div><div style="text-align:justify"><font><br></font></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>crnx-20250925.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:318da7fd-a5a8-4cea-9de6-b1786bd0a538,g:f7c2374b-5a51-4ff0-845f-44fdc0a6f28a-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:crnx="http://www.crinetics.com/20250925" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.crinetics.com/20250925">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crnx-20250925_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="crnx-20250925_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.crinetics.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>crnx-20250925_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:318da7fd-a5a8-4cea-9de6-b1786bd0a538,g:f7c2374b-5a51-4ff0-845f-44fdc0a6f28a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SolicitingMaterial_957495fa-8f54-4f9a-ab7d-bfe5b7672343_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_bdb6abeb-9fae-4192-bcb1-9bda6fab0113_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_91907934-a609-4858-af91-c47b19c4ff5e_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_d1b461cb-17e6-4efd-82c6-75336bba54cd_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_2233b64a-c795-434f-b38f-95355604fdfa_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_526a285d-410f-4170-9f37-f6c160448963_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_650c6732-1711-44c2-9074-9b403cb66c1c_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3ab6dd69-95ac-4afa-bb6c-1eca33803043_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_218fefae-6d58-470b-8795-7e77fc15b81a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_28696272-d0da-45d0-a771-7b672ddaad55_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9ba0deec-a377-49fc-8a89-59076d6f7fd3_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7ecfedca-e841-4d24-956d-0d65510ec92f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c0fb7519-ff25-4779-b8db-955fc501d843_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_06b558ed-8fb1-4bb0-9aa0-27f40dba79a9_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_3feec40b-365b-4790-b9b9-c069442bd9d9_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_0459af46-1590-464e-9dbf-1daa33ef3cd4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_789006cc-4e13-460b-ab9b-d0c0db34af9c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_7cf54ffc-c93b-4f6b-a714-5c7bc57ed7ee_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_5ca5c9cf-2f30-4f4e-84e7-d85fead5f6bf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_2df801e4-9cdf-41e4-a6cb-86548e4ddbda_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_33b4f65a-3df1-4c97-a40d-0ee3548f37f4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fc0f60ad-927b-4b0b-98c3-85fbbee948ef_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_03644522-8820-4392-ae3c-b7726ad2c71b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>crnx-20250925_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:318da7fd-a5a8-4cea-9de6-b1786bd0a538,g:f7c2374b-5a51-4ff0-845f-44fdc0a6f28a-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.crinetics.com/role/Cover" xlink:type="simple" xlink:href="crnx-20250925.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.crinetics.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_0dbbf9f2-f92e-48a9-9fa0-302b31687ad0" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_DocumentType_0dbbf9f2-f92e-48a9-9fa0-302b31687ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9ad30354-5627-4585-92d1-5cbffcc215e3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_DocumentPeriodEndDate_9ad30354-5627-4585-92d1-5cbffcc215e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_24fb8d33-bac0-4d88-9729-712f0305ca6b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityRegistrantName_24fb8d33-bac0-4d88-9729-712f0305ca6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_599853fc-fa8f-4b7b-9f52-24bea1d0eff3" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_599853fc-fa8f-4b7b-9f52-24bea1d0eff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2916fd3e-84ad-4161-90e5-264f259afa3e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityFileNumber_2916fd3e-84ad-4161-90e5-264f259afa3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c28b8aff-e4dd-44ee-a208-63f5a83beb96" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityTaxIdentificationNumber_c28b8aff-e4dd-44ee-a208-63f5a83beb96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f5827092-b12b-4572-b7f8-1afd8117aa00" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityAddressAddressLine1_f5827092-b12b-4572-b7f8-1afd8117aa00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_9358a337-4560-43da-8172-2b340cb45178" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityAddressCityOrTown_9358a337-4560-43da-8172-2b340cb45178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_fb959da9-9fd5-4bae-b62a-e7a22cd301db" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityAddressStateOrProvince_fb959da9-9fd5-4bae-b62a-e7a22cd301db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_fa3377db-c4ff-4db8-bc65-e89193d93f9e" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityAddressPostalZipCode_fa3377db-c4ff-4db8-bc65-e89193d93f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e556e3b1-c54a-4da5-96bb-12b7077d144c" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_CityAreaCode_e556e3b1-c54a-4da5-96bb-12b7077d144c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ed622935-fa30-4afb-86f1-f92902a760f8" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_LocalPhoneNumber_ed622935-fa30-4afb-86f1-f92902a760f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_87305b0b-75d0-4ac7-a655-d322abdbd811" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_WrittenCommunications_87305b0b-75d0-4ac7-a655-d322abdbd811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_ca401d84-b7b1-4778-ad56-8bfc62a1360a" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_SolicitingMaterial_ca401d84-b7b1-4778-ad56-8bfc62a1360a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_fdfeb0fd-38f4-4b5c-9267-3860275c929b" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_PreCommencementTenderOffer_fdfeb0fd-38f4-4b5c-9267-3860275c929b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_24602c2c-1adb-4bb9-a382-9ed18de2d853" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_24602c2c-1adb-4bb9-a382-9ed18de2d853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9921a615-006f-41b3-825e-0cd25fd9c020" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_Security12bTitle_9921a615-006f-41b3-825e-0cd25fd9c020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f85eff4b-d774-41ee-aa4b-914693045de2" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_TradingSymbol_f85eff4b-d774-41ee-aa4b-914693045de2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_13436bff-31e7-461f-ade3-d93caa4a9a08" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_SecurityExchangeName_13436bff-31e7-461f-ade3-d93caa4a9a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_a122e381-29d2-41e2-8030-ed3350b60370" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityEmergingGrowthCompany_a122e381-29d2-41e2-8030-ed3350b60370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_0d34b905-393f-41cb-baab-bda1500b08bb" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_AmendmentFlag_0d34b905-393f-41cb-baab-bda1500b08bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_04018c89-d7d2-4ccc-92d8-e62844d2a6f6" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdea5380-9532-4c47-aafc-5d15eba5282f" xlink:to="loc_dei_EntityCentralIndexKey_04018c89-d7d2-4ccc-92d8-e62844d2a6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img113038668_0.jpg
<TEXT>
begin 644 img113038668_0.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 'V!;L# 2(  A$! Q$!_\0
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M4Q&!HXG#TYPE[LXSJQE3::FHN+2_?&BOCG]FW]O7]E_]JIH]-^%?Q$ME\8-
M]Q+\//%ENWACQS&D4(N+DVND7TC6^O16<1WWEWX7O]<L;4!O/NDVFOL:O!QF
M"QF7UY8;'8:OA,1#XJ.(I3I5$GM+EFDW%[QDKQDM8MH^XRK.,ISW!4\QR7,L
M%FN JW5/%X#$T<50<DDY0=2C.<8U(72J4I.-2FWRSC&6@4445RGI!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT:P6#3X&59GBGO7GO)_>Z&^D=%U[OU_K_($NLM7VZ+^OZ[B          8
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MXC+L344;\M"K7KXK#U*DN6%.M/"T[N6(BC\\:***_<S^* KZA_8F\&:AX_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"<">W2*4!A]UT5ZCX@SYT/JSSK-GA^7E]B\QQ;I<EK<G)[;EY+?8MR^1\NN
M^!XXS^T(\'<+1QW-[3ZXL@RI8GVE[^U]LL)S^UO_ ,O>;VC5ES621%###;0Q
M6]O#%;V]O%'#!!#&D4,,,2".*&**,*D<4:*J1QHJHB*%4  "I:**\C?<^K22
M5DK):)+9+L%?EA_P4-_:<G\.Z:?V?/AW=RS>,/%=O!%XXNM,:26^T?0]2$1L
MO#%JMMND_MGQ3%*ANX1^^AT*:.(02G7H)K;Z^_:B_:#T?]GCX:WGB24VUYXM
MUCS]*\#:#,_S:GK1C4R7MQ$K"0Z1HD<L=]JLH*(V;33EFBNM2M"WY^_L%?L\
M:Q\0_%=[^U'\7/M.L33:S?ZCX+.K9EF\0>)GN9UU7QG=QNBQ-::5=^;::&BI
MY9U:.XNX8[5=&L&N:26LGLNG=_U_3U)DW?E6[W?9?U_6J/HO]EC]B+P#X%^%
M A^+W@GPYXO\<^-8[75/$5MXBTJQU8>%X%C9M.\.Z3//'*UC=6,<SRZO?Z=+
M#-<ZG++ MS/9V%A(,CXB_P#!,GX&^*/.N? NJ>)?AIJ$C.T<%K<'Q3X>0O@D
MOI>MSKJQVL,QI!XDMHD5G3RRHC\K]'Z*7,][ON/E5K6_K^MS\-)_V/OVUOV?
M)Y-1^"_CJX\0:3'<-<_8_!7B:?2WG"$8FUCP5XE>TT3496/2U@?Q S#J#R!M
M:!_P4+_:'^%=_!X?^/'PMCU697/FR:EI&H_#GQ5+$K".:98WL9M%O$B)62);
M70K*.4DHUV$ECEB_;&O*_C'XK^$_@[P5?:O\9)/#3>$4)C:P\2Z=::U%JMVT
M4ACT_3]$NK>[?5M0FC$FRUMK6:3RA++(([:.:5'S7>J3]-'_ ,$7+;9M?BOQ
M_,^<OAU_P4'_ &<_'?D6VJZ]J7P[U69TB%GXUTYK:Q:1L;G37]+DU/18+92>
M)]5O-+8@$M"E>.?M,?\ !0G1O#+W7@/X R67C'Q;,QLKGQO"BZIX:TB>5A"D
M/AR*+?%XJU8ELPW<9DT""1K<QG7"]Q:6WYX^(_#5C^TW\7&T;]FSX)P>#M)8
ME3!:W6H,BVC3$/XB\5S7&H7/AOPO:*H_<Z?H\$$49_T*";6KZ2V5OHO5/^"=
M'[0?P[N='\6?##QKX?U[Q'I*V]_'_8^J7OA'7=.U>.-7=-'O-2$6GW5LDOF0
M1WEYJFDR7,10SZ?#'--%$[);M)]GK][5K?UZ"YGT3=NJ5NW377[CLO@%^PAX
MR^*.M?\ "W?VHM0ULG6ITU7_ (1#4;VZ7Q;X@>0!HY?%UZ66YT"P\H11Q:):
MR1ZPL %K,=!6U2WG_8'1-#T;PUI-AH/A[2M/T31-*MTM--TG2K2"PT^QMH\E
M8;6TMDC@AC!+,51!N=F=LLS$_B]:?MA?MC? :X@TWXT^!)=?TT3B(77C'PY/
MH%Y=1QG:T&D^+?#\5OH=\W!S=S6.N2,3EI&XS]7?#O\ X*/_  0\5>1:^,K'
MQ%\-]1E=4>2_M&\0Z K/@($U;186U +O^626[T&R@B4K(\WE^8T2:D_-+167
MEV_X'Z G%=;-]VKOKJUIZ'Z#T5YYI?Q<^%FM:#/XITOXC>"+SPY:[1>:U'XH
MT9=.L&92PCU"ZDO$CL)MJL3#>-!*H4[D&#7S3\0OV_/V?/!'GVVDZSJ?Q!U2
M'<@M/!^GM+8"49V^9KNJOINE2V[$?-/I<^J%5.5B<_+4E-I;M:GVS4%S<VUG
M;S75Y<06MK;QM+/<W,L<%O!$@R\DTTK)''&HY9W954<D@5^->N?M]_M!?%*^
MN- ^!WPRCTF9\>6^EZ1J/Q%\4VZ$NJ7! L(M$M8WP9)!=Z!=Q0["/M+1QR.^
M;!^R1^V-\>KA=0^,GC:XT'399H[D6GC#Q))JC1AR6\W2O!_AM[K1M.>,,Q-I
M.^A.A)78I) =N[M\KWV?IL^XN;LF_P %]Y^@GQ"_;1_9V^'7GP7GCRU\4:I
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M=0LT=_X4G8(Z?MA%%'!''##&D,,*)%%%$BQQQ1QJ$CCCC0!41% 5$4!54
M "GT5\IFV=YKGF(6)S7&5<75BG&FI<L*5&+M>-&C3C"C23LN;DA%S:3FY2U/
MU#A;@SAG@K O+N&<HPV5X>HXSKRI\]7%8JI%-1J8O&5YU<5B913ER>VK3C34
MG&E&$7RA1117E'TX5%--#;0S7%Q-%;V]O%)-//-(D4,,,2&26::60JD<4:*S
MR2.RHB*68@ FN8\>>.?"GPR\&>)_B#XYUFU\/^$/!VBW_B#Q#K%XS"&QTS38
M'N+B01HKS7-Q(%$-G96T<MY?7<L%E9P3W4\,+_QA?MU_\%)?BU^U[XEU?P_H
MVI:QX!^ MK>R1>'?AW8WAM+G7K.$E(=9^(5Q82[=;U2]Q]K716GN- T'=#:V
M4=[>6T^MZA]9PIPAF'%6)J0P\HX;!8=Q^M8ZK!SA3<M8TJ5-.+K5Y1O)04H1
MC%<U2I#F@I_EOB?XKY#X8Y?0JXZG/,<WQZJ/+,EP]6-*M7C3:4\3B:\HU%@\
M%";5-UW2JU*E1N&'H5G3K.E_4KX__P""B_[$7PRO[K2_%7[1WP_;4++>MW:^
M%IM6^($EM+&0LEO-_P (#I?B98[N)LI+9LPNHI%>.2%71U70^''_  4#_8P^
M+&HVFD>"?VB/A[<ZMJ#01Z?I?B"]OO ^HW\]RJ-!:6-EXYL/#ES=WTGF*BV-
MO%)>>;NA, FCD1?X,Z*_5WX/Y-['E6:9FL1;^*UA'1YK;^P5!3M?[/UF]M.;
MJ?RY'Z67&'UOGEPUPT\!SW^K1>:1Q?)?X?KKQLJ//;3G_L^U]?9V]T_TCU96
M4,I#*P#*RD%64C(((X((Y!'!'(I:_C+_ ."?_P#P4^^)?[+'B+1? OQ)U?6_
M'_[/=Y<06%_H-]/+JFN?#RWE98AK?@2YN9&N([*P&)KWP@TW]D7UNMQ_9D.F
M:K.U[+_8YX>\0:)XLT#1/%/AK5++6_#OB/2=/UW0=9TZ9;G3]5T?5K2*_P!-
MU&RN$)2:UO;.>&X@E4X>*16'6OR3BCA/,.%L7"CBG'$86OS/"8VE&4:5=0MS
M0E!MNC7@G%SI.4DE).$ZD?>/ZI\-/%'(?$W*ZN+RV-3 YE@73CFF38FI"IB,
M'*JG[.M2JP4(XK!5G&<:.)C3IR<H2A6HT:EH/8HHHKY<_3 HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M,[:N&*P]>KAJB7Q4ZLH]3^^C_A(_#W_0=T;_ ,&EC_\ 'Z/^$C\/?]!W1O\
MP:6/_P ?K\=Q_P $H=>&/^+TZ-^'@B]S^?\ PDM/'_!*/7A_S6C1S]?!-[_\
MTN*_CRT?YO\ R5G^M=Y?R_\ DR/LW]N+XMZ7X)_9P\<II.L:?/K7C.*#P'ID
M5K?P32E?$?FQZT^VWE:51'X:M]:9' VK.(0QPV#Y=_P3;\(Z+X&^!=UXKU.^
MTVRUOXD>(KO5'%S>VEO=#0-!:71-%MY89)A*B"[BUS4;=I%1I8-425%,3QN_
MY8_'+]F^[^#WQ7\._"#2_%MIXZ\3>(+;0B39Z/-H\-CJ?B34Y=.TC2)8WO\
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M5^&?@#]ESX6?$D6\/AG]ISP=_:-RRQQZ)K/A6^\/ZTTS8S!!IVLZ]8S7L@+
M$Z<+R%B"8Y7 )'N@_P""9FM#I\7-)_\ ".N__FAJ;+O]Z_RN_P  YF_L_.^G
MX+^M>S/U8_M_0O\ H-:3_P"#&S_^/4O]O:&>FLZ4?^XC9_\ QZORH_X=FZWW
M^+NE_P#A'W8_]V TX?\ !,_6A_S5K2O_  D+O^OB T67>WR?Z7\^P[O^7MU]
M.]NC^]'ZJ_V[HG_09TK_ ,&-I_\ 'J/[=T3_ *#.E?\ @QM/_CU?E:/^":.M
M#_FK6E?^$A=__+_%._X=J:V.GQ:TD?\ <H7?_P OZ++O]Z].U_/[@O+^5??Z
M?\'^EK^J']NZ)_T&=*_\&-I_\>H_MW1/^@SI7_@QM/\ X]7Y8#_@FKK7_16=
M+/\ W*-W_P#+_P#K3A_P36UH?\U8TK_PD;O^NO&BR[^NC_IV^6P7?\OXK];>
M?0_4W^W=$_Z#.E?^#&T_^/4?V[HG_09TK_P8VG_QZORU'_!-G6A_S5?2OQ\)
M7G_R^Q3A_P $V]:'_-6-*'T\(W?_ ,OQ19=_P]/.W?KT^87E_+^*_P C]2/[
M=T3_ *#.E?\ @QM/_CU']NZ)_P!!G2O_  8VG_QZORY_X=N:S_T5?3#_ -RE
M=_TUX4\?\$WM8'_-5M+_  \)70_]SQHLOYOP?E^6O7IYA=_RZ^JM]_\ P#]1
M/[<T0]-8TL_]Q"T_^/4?VYHO_08TO_P86G_QZOR^_P"'<.LC_FJNE?CX2NS_
M #UZE'_!.+6?^BK:7^'A.['_ +G319=_PVVW_':^WF%Y?R_C_P #^K>A\E?\
M%X/C[/I'PQ^%/P%\-:LC0?$;6]3\9^-AI]W#(L^@^"7T^/P]I%\L3/YEGJ/B
M/5#K2H=FV]\)V<F3C;7\O%?K=_P5J_9PUG]G[X@_"(W_ (AB\2:=XN\':\+&
M[M],FTR""]T#6X3J-L(Y;Z]\V40:WI<LCJ8\)+"I#\;?R1K^J/#K#4,/PAE3
MHJ-\0L3B*\X[U*\L56IR<N\H0IPH]^6E%=#_ #(^D#F&,QWBOQ-#%N?+E[R[
M 8.E)W5#!T\MPE>$:>]H5JN(K8M]'/$SDDKV11117VY^,!7];7_!#+XX:E\0
M?V;?&/PDUN]EOK_X'>,+>#17FD\R2U\$>/H;_6-$T]BRF5EM/$6D^,Q;.\KK
M%8R6EA D-O8Q(?Y):_I"_P"#?71M1%Q^U+XA+31:2T/PBT:-,-]GO=15_B+?
M3,") IFTRV> $/$S!-77RY%!D5_@/$W#T*W"&/J54N?"5L#7P\GO&M+&4<,^
M7K>5'$58.W1W>B9^Z?1QS#&8/Q7R/#X64_8YIA,YP./A%M*IA*>58O,(\^J7
M+3QF!PM5<U[N"C'WI(_I.HHHK^7C_2P**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH XCXE^ /#_ ,5OAYXX^&?BJ%I_#?C_ ,*:_P"$
M-:2,1^>FG>(-,N=,N;BT:5)$AOK5+DW-C<%&:VO(8+A,21*1_ 1\?O@AXV_9
MS^+GC7X/>/[-K;7_  =J\]DMXL,L-CK^D.QFT7Q-I!E&Z72-?TU[?4K%B?-B
MCG-K=+%>6]Q!%_H75\1?MK?L(_";]M;P=:Z9XN,OA3X@^'8+A?!'Q.T>RM[K
M6=#\\O(^DZK9RR6R^(O"UQ<L+FYT.XO+.6&?S+G2-2TJZN+J>?\ 0. >,(<,
MXVM0QJG+*L>Z?MY03E/"UJ=U3Q,8)-SARR<*\(+GE!0G#FE25.?X/XY^$U;Q
M'RC"8W)I4J?$V1QK_4J=:4:5',\'7Y)ULNJ5I-1HUE4IQK8*M5?L8575HU73
MIXF6(H?PF45^C7[27_!+7]K']FZ'6?$&I^%-/\?_  YTJ:W7_A8'@75;.]LA
M%?WUOI^GC4?#E_-9>*],NIKJ\M+65#I%UIT=W,(+;5;U )W^=OA]^QY^U1\5
M(X;GP#^S]\6/$&G3W3646M1^"]:L/#S72,4EA/B+5;6QT)&MV&+DOJ"K:ED^
MT&+S$W?T3A^(,CQ5!8FAG&6SHN*DY_7,/'D35[5(SJ1E2DOM0J1C*+TDDS^
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M-K<.1O<,K>6MV=K)/7>ZM^E]/\[(SNF^9O3HM[>;[?/Y;(_7LD $D@  DDG
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M\G4-)OK74;*; !/E7=G+-!)@,I.R0\,#T(I%77?^OZ:-*BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK\+/\
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M%S8FA747B\-3T3K*=*$(5Z,6[U6J=*=&-IM5(*I.G^R^$WTB*'&>98?AKBK
MX7*,[QC]GEV.P4JD<KS&NDVL)*CB*E6M@L742_V=/$8BCBJEZ494*SH4:_\
M0#17Y3^-?^"D%]>SG3/A-\-7EN)Y3#9:CXQN)+JYG9R4B2+PSX>FW&9CM=0/
M$$V6/E^2WWCP(\,_M[?M#9_M>^\1^#_#5Z2&CU.Y3X:Z&MO,2R0W&C:=#;^)
M=8LBI+QR76EZP&58W>=F\@M^5V[M+\?R/Z<YUTNWY)GUK^W1\0/ T7P$\?\
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M\<_$F[MV6YU_5;;PMI$LBX(TS1(EOM2FMVZM#>ZC?V]O*22OG:-M7:4?<?\
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M7_(2Q-!_\OJ?SDE^=C]5:*^(_"?_  4B_89\9O#'H_[2GP[LVG\K8?%D^K>
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%<3X]^)/P\^%>@R^*/B7XX
M\)^ /#D3^2VM^,?$&E>'=->X,;RI:0W>JW5K%<7LJ1N8+*W:6ZN"I2"&1\*;
MA3G5G&G3A.I4FU&$(1<YRD]HQC%.4F^B2;9E6KT<-2J5\16I4*%*+G5K5JD*
M5*E!;SJ5)N,(1764I)+JSMJ*_//4?^"K7_!/[2]372;G]HK1Y;IW2,2Z=X(^
M*.KZ8&DF:!2VM:3X'O='1 ZEGE>_6..$K<2.MNZ2M].?"+]I;X _'J.5O@]\
M7? GC^YMX#=76DZ%K]G)XAL;561#=:AX9N'M_$.GVQ>1$6XO=,@A:0[%<N"!
MWXC)LXP=+V^+RK,L+0M?VV(P.*H4K/9^TJTHPL_4\++^+^$\VQ7U+*^*.'<R
MQEVOJF7YWEN,Q5UNO88;$U*MUU7)H>X445Y9\4?C!X,^$VE?;?$E]YFHW$3M
MI7AZR*2ZQJCC<H,4!8"VLPZLLVHW9BM(BIC5Y;EHK>7S3Z(]%U/5--T73[O5
M=7O[33-,L(6N+V_O[B*UM+6%,;I9[B9DBC0$@ LPRQ"C+$ _BW\8/'>E7_QI
M\1^//A;J6I:9%>2AK76+=9-+NC?3Z.-(UB^TX[Q>6T6H[[J:.>5;:\5[J658
M[9O+V>O37'QH_:Y\0_9X4_L'P+IUV&>,/<)X7T7:,J]S*%CD\1>(!#(!%&$,
MJ>=OCATFPGFE7MOCS^S=X5^'/P>T_5?"\$]WJ^@:U9R>)->NV8WFIV6JK_9[
MR-"C&WM+6WU-]-2TM($VP12RF6:XN'FN)WVZ_+T[[]58AMO9:;W=UZ;.]NMW
M\[6.V^!O[(VE:,;3QE\43:>)->G\N_L_#RRI?Z'8R2D3K<ZK<9>/Q!?-E6,6
M7TB-FE+?VJ6AN(?N955%5$541%"HB@*JJHPJJH "JH      P!BO%/V=?%I\
M8_"#PA?33":_TNR/AS4B22XN=";[#"\S$DM-<Z?'8WLC'EFN2Q )('MM)NY2
M2MIL]3YY_:L&[X!^/!Z_\(M^GC/PZ:\?^ OQ!T?X7?LS3>*]8(<6NOZ_!ING
MK($GU;5IY5^PZ; <.5,TB,\\P206MG%<7;(Z0,I]F_:D7=\"/'0]?^$8_P#4
MQ\/'^E?F?X0TC7_B$ND^$)+R2U\)>#K37/$NKW*@FUT32 _V[Q!K<R$K'+?2
M6\5O8V2.RK-.EG;;H4DN)P^G6R?RZ=>_R%]K;I\]UT[:[_Y%+3(_$'QM^+6F
M+KEQ+>:IXS\2VJ:A+$6"VFG-,K7:VB$RM!9Z3I$,OV:/+"&VM5!+%2S?MQ##
M%;0Q6\$:0P011PPQ1J%2**) D<:*.%1$5551P  !7YL?L;^$8M5\?>(?&36K
M0V?AG3&MM/C)=U@U#7WF@A6.>0%IA:Z3;ZC;R9/F8NH7<C< _P"EE#_K6_1?
MUY;= CM?2[ZVMV_7MH]PHHHI%!117'_$/QQH7PR\!>-/B-XGG-OX=\">%=?\
M7ZW,N#(NE^'=+NM6O1"K$>9<206CQV\0^::=HXD!=U!!-I)MZ)*[?9(_FM_X
M+F?M.R>)/'OA']EOPSJ(;1/ $-GXY^(R6TV5N?&NMV,@\,:+>(IX/A[PO>MK
M!0EHYI/%MN9$$^G1E?P!KO\ XJ_$?Q%\8/B5XZ^*7BV?[1XC\?>*=9\4ZLP8
MM%#<:O?378LK4841V.GQ21V%A JI';V5M!!&B1QJHX"NZ,>6*CVW]>I\[6J.
MK5G4?5Z+M%:17W)7[N[ZA1115&1)##-<S16]O%+/<3RQPP00QM+---*X2***
M) SR2R.RI'&BLSNP5020*_LS_P""8'["5A^R=\*H?&GC?2X'^/?Q,TJUN_%U
MS/$'N?!/A^X,-]IWP\L97&89;9H[:^\6R0A!>^(46R,M[8:#I-RWXN?\$:/V
M3X/C9\=[SXT>,-+%Y\/O@0]AJFG0W<"26.N?$^^+R^%K1DGC,=S#X7MX+GQ7
M=&!_.LM6M_"@N$:UU%E?^NRN>M/["?G+]%^K]4>I@*"M[>2WNJ::VMO+UZ+M
MKW04445SGJ!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%8/B+Q5X7\'Z=)J_BWQ)H/A?28@S2ZIXBUC3]$TZ)47<YDO=3N
M+6V0(OS,6E 5>3@<U\C>-?\ @HW^P[X!,BZ]^TI\.+UHBJNO@V\U'XC$%C@
M#X>Z=XH+E3Q($W>7_P M-M-)O9-^B;_(F4X1^*<8_P"*27YM'VO17Y#^)?\
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M6\9^,_AK<SA!';^/O >L8$CDCRIK[P2WC32[8IC+S7-_%:*",7!YQ]Y?#?\
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M4 %%%% !7]1'_! G_DD/Q_\ ^RD>&?\ U&)*_EWK^HC_ (($_P#)(?C_ /\
M92/#/_J,25G5_AR^7_I2.O _[S#TG_Z0S]^****XSW3YO_;(_P"30_VJ?^S;
M_CC_ .JQ\45_ ?7]^'[9'_)H?[5/_9M_QQ_]5CXHK^ ^NFAM+U7Y'DYE\=+_
M  R_-!1116YYI^QG_!#G_D]#5/\ LB?CG_T_^":_KTK^0O\ X(<_\GH:I_V1
M/QS_ .G_ ,$U_7I7)6^-^B/:R_\ @/\ Z^2_])B%%%%9'<%%%% !7E'QB^.7
MPD^ 'A*;QQ\8O'F@^ _#B.\%O=:Q<M]KU2\2)ISIVA:1:1W.L:_J9A1YETW1
M;"^OC"DDWD>5&[KQW[5'[1W@_P#94^"?BWXR>,4-[%HD,5AX>T"*86]WXJ\6
MZGYD6@^';24QS&$WDZ/<7UV(9_[.TBTU'4W@FCLGC;^';]H']HCXK?M-_$/4
M_B5\6_$EQKNM7CS1:9IT;2P:!X5TAYY)[;P]X7TII98M+T>R\S;'&'EN[N0/
M>ZI>7^I3W-Y-K3IN>KTBOO?IT]3DQ.*C0M%)2J-72>T5WE;77HEOW77]_P#X
MS?\ !>OP9I=S>:9\!?@QK'BP1EHX/%GQ(U>/PSISR)N7S[;PKH::OJ=]92G:
M\+7FOZ!>&//GV4$AV+^8?Q2_X*Z_MQ_$W[3;VWQ+TWX9:3=;]^D_"WPUI_A_
MR]V0OV;Q#JI\0>-+7RU+*GV?Q/'NR&E\R1(W3\S:*Z%3@MHKYZ_G^AY4\57J
M;U&EVC[J]/=LW\VSM/&?Q(^(GQ'OAJGQ#\>^-/'NIAF<:CXS\4ZYXHO@[@!W
M%WKE]?7&YP &;S,L  20!7%T459SMMZMW?=A1110 4444 %%%% !7L7P@_:"
M^-GP"UD:[\'/B=XN^']\TRSW<&A:K*FC:JZ*%1==\.77VGP]K\*A4*V^MZ7?
MVX:.-Q$'CC9?':*&D]&KKLQIM---IK9IV:]&C^E;]DS_ (+C66J76F^#?VMO
M#=IHDD\L%I!\7/ NGW1TJ/>5C^T>,O!J/>7EHH(::ZU?PJ]W$6=8XO"EI#&]
MP?Z#/"_BGPUXW\/:1XM\':_H_BGPOK]G'J.B>(- U&UU;1]5L9<B.ZL-0LI9
MK6YA+*R%HI&"R(\;[9$91_G.U]^?L,_M_?%']C/QC;PVUUJ'BWX,ZUJ44OCC
MX97-V6MF20>3<>(?!YNG,&@^*[>(I(TL)@LO$,=K;:=KH>.'3[[2\)T4[N.C
M[='Z=G^'IN>AA\=*+4*SYHNR4_M1_P 5OB7=_%UUV/[A**\W^$?Q;\ ?'/X>
M>&OBE\,=?MO$G@WQ78B\TS48 T<L4D;M!>Z;J-I)B?3M7TN\CFL-4TZZ1+BR
MO8)8)5RH)](KFVW/6332:=TTFFMFGJG\PHHHH&%%%% !1110 445\S?M4_M7
M_"G]D7X:WGQ#^)FI[[F?S;/PCX,TZ:W/B?QMK:H&33-%M)G79;0;XYM8UFX
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M.J^']8L9!+9:MHFHWFE:G9R@@B2UO[":"ZMY 0"'BE1@0"#Q6;H1>S:]=?\
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MN314SJN47'E2O;6_9I_H:T<$J-2-15')I-6<4KW5M[OO<****Q.X^;_VR/\
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M9O+:(3A+F?2KK[9H6HRQ1C5=+OHT"5I&N]I)-=UH_6VS^5CEJY?!INE)Q?\
M++6+\K_$O5\Q_ ?17WK^W-^P+\3?V*O%UN-4F;QE\*/$UW-%X(^)5C926UO<
M3(LDQ\-^*+0&:/0?%=O;1O<):_:)[#6;&.34-'NIFM=6L-(^"JZ$TTFG=/9G
MESA*$G&<7&2W3_K5/HUH^@5])_LI_M0_$3]DGXNZ'\4_ -R]Q# Z6'B_PE/=
MSV^B^-_"TTBG4- U98MRJY7_ $K1]1:"XDT;6(;/4HH+@026MQ\V44VDU9ZI
MBC)QDI1;4D[IK=-'^A1\#_C1X%_:#^%OA'XN?#G4O[1\+>+]-2]MUE,2ZAI5
M[$S6^J:%K%O#+,EIK.BW\=QIVI6PED1+B!G@EGMI(9Y?6*_D9_X(W_MA3_!7
MXTK\!/&&IF/X9?''5K.RTC[5,XM?#7Q3D2.P\/WUN&D\J"'QBBVOA750L1DN
M;]/"T\DT-MIL_F?US5Q3AR2MTW3\O\^Y]!AZRKTU+:2]V:[225VO)[K[KMIA
M1114&Y_,W_P< ?\ (W_LR?\ 8M_%#_TZ>":_GCK_ $(/BA^S]\$?C9/H]U\7
M/A5X&^(]SX>AO;?0Y_&'AW3]<DTF#47MY+^*P>^AE-LEW):6KW"QE1(UO$6R
M47'E?_#!O[%__1L'P3_\(#0/_D.NB%:,8I-/332QYM?!3JU9U%."4FK)WNK1
MBNBMT?X=]/X,Z*_O,_X8-_8O_P"C8/@G_P"$!H'_ ,AU\D_MX?L=?LK> _V/
M_C]XP\&?L^_"?PQXIT#P%=W^B:_HG@S1M/U72KU+ZQC6ZL;VWMDFMYU21U$D
M;*P5F&>35*M%M*SU:73K;S]?Z>F$L!4C&4G.#48N37O=%=K;U_#OI_'31116
MQP!117[D?\$3_@;\'OC9XH_:#M?BY\-/!GQ'MO#V@_#NXT.#QAH-AKD>DSZC
MJ/BZ._EL$OHI1;/=QVEJEPT84R+;Q!LA%Q,I*,7)ZI6V\VE^II2INK4C332<
MFTF]E9-]/0_#>BO[S/\ A@W]B_\ Z-@^"?\ X0&@?_(='_#!O[%__1L'P3_\
M(#0/_D.L_;Q[2_#_ #]?Z>G9_9U7_GY3_P#)O\O7^GI_!G17]YG_  P;^Q?_
M -&P?!/_ ,(#0/\ Y#H_X8-_8O\ ^C8/@G_X0&@?_(='MX]I?A_GZ_T]#^SJ
MO_/RG_Y-_EZ_T]/X,Z*_O,_X8-_8O_Z-@^"?_A :!_\ (='_  P;^Q?_ -&P
M?!/_ ,(#0/\ Y#H]O'M+\/\ /U_IZ']G5?\ GY3_ /)O\O7^GI_/'_P0=_Y.
M\^(W_9M_B_\ ]6=\'Z_K0KP_X:?LT?L^_!K7;OQ1\*/@W\._AYXBO](GT&]U
MKPEX7TS1-2NM%NKRPU"XTN>ZLH(I9+&>^TO3KN2W9C&\]E;2$%HD(]PK"I)3
ME=76BW/0PU&5"ER2:;YF[J]M;=[!1114'0%?Q/\ _!7'_E(5^T%_W2C_ -4C
M\-:_M@K^)_\ X*X_\I"OV@O^Z4?^J1^&M;4/C?\ A?YHX,Q_@0_Z^Q_](F?F
M_11174>,%?Z+G@W_ )%#PK_V+>A_^FNUK_.CK_1<\&_\BAX5_P"Q;T/_ --=
MK7/7^Q_V]_[:>GEN];TA^<CI****YSU0HHHH *IZCJ-AH^GW^K:K>VNFZ7I=
MG=:CJ6HWT\5K96%A90/<WE[>74S)#;6MK;Q23W$\SI%##&\DC*BDBY7\^'_!
M;#]LZX\+Z+9?LC_#S5FM]9\5:?:Z]\9+^RD9)['PK<%)_#W@D3QMNCD\3-&V
ML^((/W4O]@P:19N;C3O$5]!51BY227S?9=7_ %UT,JU6-&G*I+IHEUE)[+_/
MLDWT/S:_X*6?\%!]>_:U\>W7@7P)J5_IG[/?@K4Y(_#NEH\EJ?'VLV3RP/X[
MU^ !)9(9=SQ^%M*N]RZ5IA%]+!;ZMJ5_%#^6=%%=J2BDDK)'S]2<JDW.;O)O
M[NR79+9(****9 45^P_[&O\ P1^^,G[05II7CWXPW5[\$_A7?+!>6$-[I_F?
M$CQ=ITR+-#<Z)X?O52W\/:7>1$FWUSQ*!/(CVU[IOAS6=.N$NQ_0[\#/^"=?
M[(/[/]M8OX1^#_A[Q#XBLTBSXV^(MM;^.O%<UW$$_P")C!=:W;RZ9H5ZYC#.
M?"VDZ#;@M((K>-))%;.56,=/B?9?J]CKI8*M52DTJ<7UE>[7=1W?SLGW/XI_
M!7P5^,GQ*C$OPZ^$OQ,\?1,SHLO@KP'XI\51L\:/)(@?0M*OU+1QQO(Z@Y5$
M=V 521[[8?\ !/3]MO4HWEM_V9?BO&L;^6PO_#KZ5(6VALI#JDMG-(F& \V.
M-H]VY-^Y6 _NU1$C1(XT6..-52.-%"(B( JHBJ JJJ@!5       IU9.N^D5
M\VW_ )'6LMA]JK)^D4OS<C^#'6_V$/VSO#PE.H?LP_&R58?+\QM'^'_B#Q&H
M$B[PRMX>L]46157_ %KQEE@(*S&-@0/G?Q/X%\;>"+D6?C/P=XJ\(W9(46OB
M?P]J^@7)9O,V@0:K9VDI)\J7 VY/E28^XV/]%:JE_I]AJEI/I^IV5IJ-A<J$
MN;*_MH;RTN$#*X2>VN$DAE4.JN%D1@&56 R 0*N^L5\G;_/[OQ!Y;'[-62?G
M%/\ )JWXG^<517]X?Q(_8%_8U^*_GOXQ_9U^&K7=SDW.J>&-%/@+6KB0[?WU
MSK/@2?PWJEU. JJLMS=S.$419,7R5^?'Q/\ ^"$G[.'B5;BY^%WQ'^)7POU&
M7?Y5MJ9TKXA>&;7))C\K3+V/P]XB?86VOY_C&7S(TC"^7())9;5:+W37XK\-
M?P.>>7UHZQ<)^2?*_NDDO_)C^4.BOV8^*W_!#W]K/P8UQ=?#G5OA[\8M-0,;
M>WTO6_\ A#/$\H4D_OM*\7BQT" NNTHL/B^\8MO1@FU&D_,OXJ?L\?'3X(7+
M6_Q;^$OC[P OG>1#J'B/PUJ=EHE[*<?+IGB#R'T/51D[=^FZC=)O!3=O5E&B
MG&6TD_+K]VYRSHU:?QTY1\VG;_P)73^3/&Z_MV_X)7>!!X"_82^!-I)$L=]X
MFTG7?'=_(J*AN#XQ\4:SK6E2OM&69/#UQHUMO<LQ2W3!50J+_$=;P374\%K;
M123W%S-'!;P1*7EFFF=8XHHT4%GDDD9410"68@ 9-?Z'WPK\&0_#CX8?#CX>
M6Y4V_@/P%X/\&0%%5$,/A?P]IVAQ%$0E%798KM5"548"D@ UE7>D5W;?W?\
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M+U)-*N?V7/CC+=2/+&LNG?#KQ)J^FAH0&<OK.DV%[H\:$']U+)?+'.<K"\C
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MJG_9$_'/_I_\$U_7I7\A?_!#G_D]#5/^R)^.?_3_ .":_KTKDK?&_1'M9?\
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MI8=0TC5+4I>:;J-O;7MK)'/"C#^&3]L3]E_Q5^R-\=/%'PD\0M<:AI4)77/
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MN^/_ !?X<\&Z09%9H8]0\2ZO::/:SW&W!6VMY;Q9[F0E5C@CDD=E568?W_\
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M^S;_ (X_^JQ\45_ ?730VEZK\CR<R^.E_AE^:"BBBMSS3]C/^"'/_)Z&J?\
M9$_'/_I_\$U_7I7\A?\ P0Y_Y/0U3_LB?CG_ -/_ ()K^O2N2M\;]$>UE_\
M ?\ U\E_Z3$****R.X**** /XY_^"U7_ "?'KW_9-_AY_P"F^[K\EZ_6C_@M
M5_R?'KW_ &3?X>?^F^[K\EZ[H?!'_#'\D?.XC^/6_P"OD_\ TIA1115&)_?A
M^QO_ ,FA_LK?]FW_  ._]5CX7KZ0KYO_ &-_^30_V5O^S;_@=_ZK'PO7TA7!
M+=^K_,^EI_PZ?^"/_I*"BBBD6%%%% !1110 4444 ?P _M9>%(/ W[4/[1'A
M&T6*.QT'XU?$RPTV.'.R/2T\8:N^EQX(&QDT][9)(QN$<@9%=U4.WS[7VO\
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M^%_FC@S'^!#_ *^Q_P#2)GYOT445U'C!7^BYX-_Y%#PK_P!BWH?_ *:[6O\
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ME:N2%N+#4].GN;.[A)!7S()G7<"I.00-RN4]G?8**** "BBB@ HHHH ****
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M\X**62"2.:&1X9H726*6)VCDBDC8/')'(A#(Z, R.I#*P!!! -?0G@;]K?\
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M2PN]%UB93C%7;7DNK_KOL:TJ%6K)1C%V>\FFHI=VWI\MWT/W>_9_\$WOPU^
M_P %/AUJ:[-3\!?"7X<^#-27*,1J'ACP?H^BWVYXU6-V-U92EW155V)8  UZ
MY117#N?0I)));))+T6@4444#"OB?_@H[_P F.?M+?]DWO?\ TX:=7VQ7Q/\
M\%'?^3'/VEO^R;WO_IPTZJA\<?\ %'\T9UOX57_KW/\ ])9_"O1117<?-A7]
M#G_!O_\ \C?^TW_V+?PO_P#3IXVK^>.OZ'/^#?\ _P"1O_:;_P"Q;^%__IT\
M;5G5_AR^7_I2.G!_[S2]9?\ I$C^F2BBBN,]\**** "BBB@ HHHH **** "O
MXG_^"N/_ "D*_:"_[I1_ZI'X:U_;!7\3_P#P5Q_Y2%?M!?\ =*/_ %2/PUK:
MA\;_ ,+_ #1P9C_ A_U]C_Z1,_-^BBBNH\8*_P!%SP;_ ,BAX5_[%O0__37:
MU_G1U_HN>#?^10\*_P#8MZ'_ .FNUKGK_8_[>_\ ;3T\MWK>D/SD=)1117.>
MJ%?$_P#P4=_Y,<_:6_[)O>_^G#3J^V*^0_V^]+&L?L5_M.VABN)O)^#?C35-
MELK-(#H>E2ZV)6"HY%O =/$UVVT*EK',S/&H,BU#XH_XE^:,ZNM*HN].?_I+
M/X.Z***[CYL*_43_ ((Y?\G[_"__ +%OXF_^H!K]?EW7Z2_\$C=8&D?M_P#P
M,622**WU:+XD:/.\B.YS=?"OQK+9QQ;.4EFU.VL8 [*R!)'#[ ?,29_#+_"_
MR9K0_C4?^OM/_P!+1_:W1117"?1A1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 (RJRE6 96!5E8 JRD8((/!!'!!X(X-?AI^VM_P1F\!_%FYU;XC
M?LS7&B_"OQ]=O-?ZIX O$DM/AGXEN6\R65]'2QMYY? NIW#MA8;"TN?#$SK%
M$NEZ(9+K4F_<RBJC)Q=XNWZ^IG5I4ZT>6I&ZW3V:?=/=>?1];G^?+\:?V>?C
M5^SOXD?PK\9OAUXC\"ZH7D6RGU2T$NB:RD1P]QX>\1V#W>@>(+53P]SHVI7L
M4;AHI6CE1XU\9K_1?\4^$O"OCG0[[PQXT\-:!XN\.:G'Y6HZ!XFTC3]=T:^C
M!R$N],U.WNK.X"GYE\V%MK89<$ U^77QD_X(R?L;_$Z6[U+PGI/BOX+ZW<;I
M?,^'VM^?X=DNFP ]QX6\40:[8V]L%&/L7AVX\.P[@'4JQE\W>-=/XE;S6J^[
M?\SS*F735W2FI+^67NR]$_A?J^4_CEHK]\?B-_P00^,>ERW$OPJ^-_P[\96:
M[I(+;QOH_B#P%J10Y86RMH\?CRPN)T&(UGEGT^&X8&5X[-6\M/B?QY_P2?\
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MS1Z^JZ::NY[E11169UA1110 4444 ?SE?M/>";SP%\=OB1H]S#)';W_B2_\
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ML]"UCPMJ"2!@\)M589>VFAOK:6>W;&X>2Z1O+&P.T.&V[A,"NJ-*%UX"AG"
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MDQ)JOA?2-.M(VN]7(D_J?KBJ1Y9-=-UZ/^K?(^APU55J,97]Y+EGWYDE=_\
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M.?M+?]DWO?\ TX:=50^./^*/YHSK?PJO_7N?_I+/X5Z***[CYL*_H<_X-_\
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MH3CZ2BTU\F8XC#8?%TIT,50HXFA-6G1Q%*%:E-+5<U.I&4)6>JNG9GP9<_\
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M?]E(O?\ TWZ=7Q/7=#X(_P"&/Y(^:J?Q*G^.7_I3"ND\&_\ (W^%?^QDT/\
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MV&4$=B(]BD'N#GTKFM8)U+78+%3E(C% <'@;OWMPWU5#AL?\\\=:[L
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MO+74-/OK>&[LK^QN(;NSO+6X198+FUNK=Y(+BWGB99(9H7>.1&5T9E()M5_
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MDVPW&H^ ?$UK8V\'E[QYER-/\=:M<0GRVV6]O>?.F[;)^$%?H/\ \$L?'O\
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M4HM*=:K)-QIQ;T6B<I2:?+",I6;2B_:?&W[2?PW\'W$^GP75UXGU2!FCEMM
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MH"T^UW2P(L*SS2")50*!UE<)]"KV5U9V5UV?5!1110,_A7_X*._\GQ_M+?\
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M%]8W%O>6\,\=PFX/NGNOU7F<^(P\:\;/2:^&7;R?>+_#=>?^=717[9?MT_\
M!(#XB?!>ZUKXD_LXV>L_$_X2E[C4;WP?!')J7Q$^']KQ)+"MK"&N?&OAVU)9
MK?4].@?7]/L@$UO3[N*QNO$=Y^)Q!4E6!5E)#*0000<$$'D$'@@\@UV1DI*Z
M=_S7JCPZE*=*7+.+3Z=FNZ?5?T[,2BBBF9A4L%Q/:S17-K/-;7$$BRP7$$CP
MS0RH0R212QLLD<B, 5=&#*0""#45% 'K6E_'WX[:';"ST7XU?%K1[,;,6NE_
M$?QCI]L/+C6),06FLPQ#9$B1IA?EC14&%4 :7_#2W[1O_1?_ (V?^'5\=_\
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M;K]N%*"#6O$>L:K"$9TD9!%?7DZ;3)'&Y7;@O&C$;D4CDJ** "BBB@ HHHH
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MQ&,LB9/G/:^.M3\0:?&[,2S+;V<$(.T)$JHBK+K0Z)OY6-(Y?7>[A'UDV_\
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M#Y^:.ZTN>+@;$7G*=:'F_1?YM?TO0J. KO?DCZRO_P"DIG\68!8A5!9F("J
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MBF#!I$N4W*B/VM/O?Y/]42L#B7]A+UG']&S^4:BO[4/!?_!(?]@[P<\=Q/\
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M_M")7&&L]+S(8YAP^I"+R7)LYU'JO@;]D[PIH-S#J/B[4YO%EU"RR1Z:EO\
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MUVWU +%+M@N\8,9.$E/<PL3DD]?+8[QSC> 6H WJ*** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M%?D)_6(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGA/J\(T</B:\<.\136+J87#8M2PU?$0H\SC3K0J)P]HX4YU53B_IO]@_]O\
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M:K^+VM_ 3]G;XM?&+PWIFE:SKGP^\*7&OZ9I>MB[.DWMS#=6L"PWPL+FSO#
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MW0&UO<PVWBCPM?O%;RZEX=O+N*6VGAEA74?#]Z8;#5/-BO-(U35_T$K^(_\
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MJXS&YGEV$Q=3#X?-:6!QV55'AL7"+=.K"K2=:@U4A./)6FG%QDT_Z:OVZO\
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M5^$WA'X;Z5:7,]F;_P"(*ZCXO\9E[:9HV>6PM;GP_H&A7)*&.ZTNYLO$1MI
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M ."QO[+/P\_9R^/?A#7OA5X?L/"'@SXN>%;[7)/"6D6Z6FAZ)XJT#5!8Z^-
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MC/3OBKX%^,?ACX1V7@OQ?X \1Z?XJTF#PIJ6HZ=X7O-6T>8W>D2ZCX2GGO-
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M]?3?_!:G]HG5?@Y^S#I_PX\+ZE-IGB;X^:[>^$;NXMI?)N4^'NC6"7OCI()
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M#UD=1(!]) /TKT<$$ @@@@$$'((/(((X((Y!'6EH \]'BO4@,&*S;W,4V?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM\4_A/-9Q;I8XSO30_&NLZ@=B.T[>78R9BAD";YS##+]V_\ !OQ_R.'[3O\
MV+7PN_\ 3IXVK^FVOO.+_$3.\AS['93@L-E<\/AXX5TZF(H8J=>]?"4*\^:5
M/&TJ3M.K)1M25HI)\S3D_P -\)O '@SCC@?)N*,XS#B6ECL=5S*-?#X#&Y91
MP7+@LSQ>"I*$*^3XG$QYJ6'A*HWBI-U')P<(M1C_ #7?LY_\$&]1BU?3]?\
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M[O2]-"Z@)#)]EM;Y1/!/YBB*.96 [W_@C9_R?U\+?^Q;^)W_ *K[Q!7[+_\
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M:226!KVC&[7-.I)QITX+WIU)1A%.4DG_ !>_!K_DL'PI_P"RD^!O_4HTNO\
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M^(-A:/?R>';&XD9X- ^(,=G&QT75=.#)9IK<\-MH7B%1#=V$UK?3W>B:9G?
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M;1ZEI0AU#2[PPW.DZWH>O>']<M'1TFMYKO3=4TG5;$E=\B/%%<1(\?Z<ZO\
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MM$UK2KJ&^TO5](^&W@W3=4TV^MG$EO>6&H66BPW=G=02*LD-Q;S1S1. R.K
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M9S<'CS8'VG#+A@"/J;P?X$\$?#S1XO#W@#P;X5\#:! =T.A^#_#VD>&='A;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :Z)(K)(JNCJ5=& 96
M4C!5E.001P01@BN(U'P7%*S2Z;.+<L<_9Y]S0@G^Y*H:1%']UDEZ\,  ***N
MG.4&N635VDUNG\G=?/<PKTJ=2#YXJ3BFT]4UMLTT]>JO9G)OH-XCE#);9!P2
M'EQG\80?TKH[#P46*2W]TAC(#>3:AB7!Y ::14*#'#!8B3D[74@&BBNNK4G&
M#:E9W2O9=?D>=AJ-*=62E#F2NTFY6T>E]=?1W3ZG>6]O!:PI!;Q+##&,(B#
M'<DYR68G)9F)9F)9B22:FHHKAWW/72222222LDM$DMDET2"BBB@84444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_
!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 25, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 25,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Crinetics Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-3744114<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6055 Lusk Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">450-6464<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRNX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001658247<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="crnx-20250925.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.crinetics.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="crnx-20250925.htm">crnx-20250925.htm</File>
    <File>crnx-20250925.xsd</File>
    <File>crnx-20250925_lab.xml</File>
    <File>crnx-20250925_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "crnx-20250925.htm": {
   "nsprefix": "crnx",
   "nsuri": "http://www.crinetics.com/20250925",
   "dts": {
    "inline": {
     "local": [
      "crnx-20250925.htm"
     ]
    },
    "schema": {
     "local": [
      "crnx-20250925.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "crnx-20250925_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "crnx-20250925_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://www.crinetics.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crnx-20250925.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "crnx-20250925.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.crinetics.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001658247-25-000008-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001658247-25-000008-xbrl.zip
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M'/6.=Y.#=.QW*0EM*1,F7B0/)]^C/)29X1YYN\E#-O9@H\4-[99SQY9&.DQ
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MN%(A'X .:>,".A1SG3XFDNE10.:L#H^7YD.=4J:W;)&:>J]HBIOK#QR@A,2
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M;-5_;8M^!-N"H@YZY+81: [I RP9Z>IRAHF??==CE]@+(5AP))3$ND\;IS^
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MQ]W$]Y6=E-)_AD[_VW47_P502P,$%     @ D(PY6SJ2"P9A @  _ 8  !$
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M5UY+[\^\^)[^H-[YDI8J+U8 G-1/.\UO'HKTZKKT0C]$NV6[1XLW49 (BI4
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MN\-WL,-4,.'IXW@R]Z:&=XLG)%[@B9.#AR^ZE^X/\2<'_P=02P,$%     @
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M9>ZDF</Z_"\7D1_\MJ.SB- 07Z10 ]"!XC]V=K8W]G<V=C96?=M^R0R5STG
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MK1RI4E'V3@(IJ2CASHIIB]X>1Z19;AJQ'"64^#Q)JH@S+"E$Q-4;64L:&^3
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M6_( G#0MQ)1YL:W2Z8B:H+FU"$Y&INE]]F\=L=CGL",<>:5:K4#JIPIWK5'
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M.3(U+FAT;5!+ 0(4 Q0    ( )",.5LZD@L&80(  /P&   1
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7;5!+!08     !0 % $<!  #!0@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>crnx-20250925_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="crnx-20250925.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001658247</identifier>
        </entity>
        <period>
            <startDate>2025-09-25</startDate>
            <endDate>2025-09-25</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0001658247</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-09-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Crinetics Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38583</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">26-3744114</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">6055 Lusk Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">450-6464</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">CRNX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
